Visfatin Levels Before and After Periodontal Treatment
VL
Gingival Crevicular Fluid and Serum Levels of Visfatin in Periodontal Diseases Before and After Non-surgical Periodontal Treatment
1 other identifier
observational
45
0 countries
N/A
Brief Summary
The purpose of this study was to evaluate visfatin levels in different stages of periodontal diseases and health, moreover the effect of non-surgical periodontal therapy on visfatin levels in Gingival Crevicular Fluid (GCF) and Serum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2012
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 23, 2015
CompletedFirst Posted
Study publicly available on registry
November 26, 2015
CompletedNovember 26, 2015
November 1, 2015
1.4 years
November 23, 2015
November 24, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visfatin levels: Change after periodontal treatment both in serum and GCF
baseline, 1, 3 and 6 months
Study Arms (3)
Group 1
Periodontal healthy
Group 2
Gingivitis, Non-surgical Periodontal Treatment
Group 3
Chronic Periodontitis, Non-surgical Periodontal Treatment
Interventions
Non-surgical periodontal therapy is an anti-infective therapy which includes both mechanical and chemotherapeutic approaches to minimize or eliminate microbial biofilm, the primary etiology of gingivitis and periodontitis
Eligibility Criteria
Total of 45 patients
You may qualify if:
- GI\>1, PPD≥5mm, CAL≥5mm with alveolar bone loss radiographically.
- Systematically healthy patients
- No alveolar bone and attachment loss
- Inflammation signs such as redness, edema and increased BOP levels,
- GI≥2, PPD≤3mm, CAL≤3mm.
- Systematically healthy patients
- No bone and attachment loss,
- GI=0, PPD≤3mm, CAL≤3mm
- Systematically healthy patients
You may not qualify if:
- Aggressive Periodontitis,
- Oral pathologies,
- Patients with any other systemic diseases,
- Pregnant women and those in the lactation period,
- Patients with smoking habit and taking medication
- Patients received periodontal therapy in last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Gingival crevicular fluid and Serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ÇİĞDEM COŞKUN TÜRER, Ph.D
BULENT ECEVIT UNIVERSITY FACULTY OF DENTISTRY DEPARTMENT OF PERIODONTOLOGY
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
November 23, 2015
First Posted
November 26, 2015
Study Start
May 1, 2012
Primary Completion
October 1, 2013
Study Completion
January 1, 2014
Last Updated
November 26, 2015
Record last verified: 2015-11